Neuroplasticity
Search documents
The Smartest Generation? Neuroplasticity in Children | Alex Hayward | TEDxKings College School
TEDx Talks· 2025-11-07 16:26
Neuroplasticity & Child Development - Neuroplasticity is the brain's ability to reorganize itself in response to new information [3] - Children's brains have a high number of synapses, peaking around age 2-3 with one quadrillion (1,000,000,000,000,000) synapses, making them highly sensitive to new information [3][4] - Early language learning exemplifies neuroplasticity, enabling native-like accents and complex grammar understanding [7] - Early years significantly impact a child's development, influencing their future [8] Examples of Neuroplasticity - Chess prodigies demonstrate neuroplasticity by quickly identifying patterns and memorizing sequences [5][6] - Children can outperform adults in certain skills due to their neuroplastic brains [2][6] Implications for Education - Providing the right environment is crucial for young people to achieve their full potential [9]
What If I Told You Your Brain is Like Play Doh? | Carla Winzer | TEDxYouth@FIS
TEDx Talks· 2025-11-07 16:23
[Applause] What if I told you your brain was like play-doh. It's soft, malleable, and everchanging. Each one of your thoughts leaves an imprint just like this.The more you repeat this thought, the deeper the imprint becomes. This is how your brain forms neural pathways. We all have good and bad days and our brain takes note of them all.Good and bad thoughts leave a mark. But the good news are these marks are reversible. You are never stuck.You can always reshape your brain. And the term for this is neuropla ...
Solana Company Files Application to Cease to Be a Reporting Issuer in Canada
Globenewswire· 2025-11-04 21:05
Core Viewpoint - Solana Company has applied to cease being a reporting issuer in multiple Canadian jurisdictions, which will relieve it from filing financial statements and continuous disclosure documents in Canada while continuing to comply with U.S. securities laws [1][2]. Company Overview - Solana Company (NASDAQ: HSDT) is a leading neurotech firm focused on addressing neurologic deficits through an orally applied technology platform that enhances the brain's physiological compensatory mechanisms and promotes neuroplasticity [5]. - The company also operates a digital asset treasury (DAT) aimed at acquiring and holding Solana (SOL), with the goal of maximizing SOL per share through strategic capital market use and on-chain opportunities [5]. Regulatory Actions - The company has requested an order from the British Columbia and Ontario Securities Commissions to stop being a reporting issuer in Canada, which would eliminate the requirement for financial disclosures in those jurisdictions [1][2]. - If granted, the company will continue to file necessary financial statements under U.S. securities law and Nasdaq rules [2].
The Neural Tango in Community | Martha Summa-Chadwick | TEDxAnchorage
TEDx Talks· 2025-10-29 15:16
music. It's a gift of therapy to the body and beauty to the soul. [Music] That was a short segment of a lovely piece by Johan Sebastian Bach.Here's another song you're probably familiar with. [Music] That was Twinkle, Twinkle, Little Star. These two pieces I just played have very different formats.One is woven into a beautiful harmonic tapestry and the other is a simple melodic line. But when learning either of these pieces, it all starts with figuring out how to play just one note at a time. I became fasci ...
HOW TO REWIRE YOUR BRAIN...
The Diary Of A CEO· 2025-10-23 21:00
Neuroplasticity & Learning - Brain plasticity allows for learning and unlearning at any age, overcoming traumas is also possible [1] - After approximately age 25, significant neurochemical shifts are required for brain change [2] - Traumatic events are remembered due to neuromodulators like epinephrine (adrenaline) causing a state shift [2] - Therapy can reduce the emotional impact of traumatic memories [4] - Alertness and focus are key for neuroplasticity in adults, passive learning is ineffective [4] Neurochemical Processes - Attention triggers the release of catecholamines (dopamine, epinephrine, norepinephrine), increasing alertness and focus [5] - Increased alertness and focus lead to a tightening of visual and auditory fields [6] - Adequate sleep after focused attention consolidates new knowledge through neural connection reordering [6]
Why we need neuroscience at school | Roshan Amurthur | TEDxWoodcreek HS
TEDx Talks· 2025-10-20 16:02
[Applause] [Applause] When I walked into that seventh grade classroom, I was carrying something a little bit weird. A homemade brainwave reading headset made from wires, tape, and a little hot glue. Most of the kids were laughing, but one skeptical 12-year-old raised his hand and asked a question.Can I try it. He slipped the headset on, watched his brain waves dance on the screen, his eyes widened, and he said something that I would never forget. If my brain runs on electricity, can I rewire it.For me, that ...
The Science of Burnout — And How Your Brain Rebuilds You! | Agastya Sharma | TEDxYouth@JGIS
TEDx Talks· 2025-10-17 15:47
So, imagine living in a room with no windows, no sunlight, no fresh air, no way to tell if it's morning or midnight. At first, you think you'll adapt. You breathe the stale air.You keep working. You keep going. You tell yourself it's fine.But after a while, something strange happens. You stop noticing. Time pass.You forget how it felt to feel motivated. You don't crash. You just fade.And that's what burnout is. After my IGCSC exams, I thought the hardest part was over. But I didn't realize how deeply burned ...
Why mental fitness beats perfection | Dr Pretty Basra | TEDxDoncaster
TEDx Talks· 2025-10-16 15:21
I'm Dr.. Pretty Bazra and I am a failure. And I say that not as a confession. I say it as a celebration. Over the all the times that I've failed, I started to notice a pattern almost like a system. And it took me a little while to name that system. I now call it fail mental fitness framework. So I'll talk to you about that a little bit later on. But before that, I'd like to take you back to the classroom. So, I'm an optometrist. I deal with numbers every single day. I own three businesses which again lot of ...
Healing isn’t always linear | Dr. LaTanya Runnells | TEDxDel Sur Women
TEDx Talks· 2025-10-09 15:12
Core Concept - The brain is likened to a computer with components such as the prefrontal cortex (operating system), limbic system (emotional headquarters), amygdala (alarm/firewall), and neuroplasticity (software update) [2][3][4] - A mental breakdown is not a sign of weakness but a reset mechanism indicating the brain's current wiring is insufficient [16] - Healing from a breakdown involves a process that may initially worsen symptoms before improvement [10][11] Brain Function During Stress - Constant stress triggers the amygdala, acting as a smoke detector, to sound an alarm [5][6] - During a breakdown, the prefrontal cortex, responsible for logic, memory, and problem-solving, becomes overwhelmed, leading to a shutdown of these functions [7][8] - Raw emotions from the amygdala, such as anger, aggression, and sadness, surge during a breakdown, causing a feeling of loss of control [8] Neuroplasticity and Recovery - Neuroplasticity is the brain's ability to rewire itself, enabling recovery and growth after a breakdown [4][14] - New choices, prayers, and exercises can create new neural pathways, calming the amygdala, strengthening the prefrontal cortex, and restoring balance [15] - The brain that experiences a breakdown is the same brain capable of rebuilding and functioning effectively [14][15]
NRx Pharmaceuticals (NasdaqCM:NRXP) Conference Transcript
2025-10-08 14:32
Summary of NRx Pharmaceuticals Conference Call (October 08, 2025) Company Overview - NRx Pharmaceuticals is a micro-cap biotechnology company focused on developing treatments for mental health conditions, particularly suicidal ideation and depression [3][4] Key Programs and Developments - **NRX-100**: An intravenous ketamine formulation aimed at treating suicidal ideation and depression, with a fast-track indication granted by the FDA. The company is engaging with the FDA for a new drug application (NDA) [4][3] - **Market Potential**: The addressable market for NRX-100 is estimated to exceed $2 billion, based on the efficacy data from clinical trials and real-world data from over 180,000 patients treated with ketamine [4] - **NRX-101**: A fixed-dose combination of D-cycloserine and lurasidone, which has received breakthrough therapy designation. It aims to reduce suicidality in patients with akathisia [5][6] - **Hope Therapeutics Clinics**: The company is establishing a network of clinics to integrate medications with neuroplastic therapies like transcranial magnetic stimulation (TMS) and hyperbaric oxygen therapy [6][8] Competitive Landscape - **Johnson & Johnson's S-ketamine**: The only approved nasal spray for depression, which does not lower suicidality. It generated $1.3 billion in sales last year [5] - **Market Dynamics**: There is a current market of $750 million for ketamine, which is often in chronic shortage, leading providers to compounding pharmacies [8] Clinical Insights and Data - **PTSD Treatment**: Recent studies indicate that intravenous ketamine significantly reduces PTSD symptoms, with 12 million Americans affected by PTSD and no approved drug available [8][9] - **Suicidality Statistics**: Over 50,000 Americans die by suicide annually, with significant numbers of individuals contemplating or attempting suicide [10] - **Neuroplasticity**: The company emphasizes the neurobiological understanding of suicidality, focusing on NMDA receptor antagonists to promote neuroplasticity and improve treatment outcomes [11][13] Regulatory and Strategic Initiatives - **FDA Engagement**: The company is pursuing a Commissioner's National Priority Voucher (CNPV) to expedite the NDA process for NRX-100, which could significantly shorten the timeline for approval [4][27] - **Citizen's Petition**: NRx Pharmaceuticals has filed a petition with the FDA to remove toxic preservatives from ketamine formulations [7] Future Directions - **Combination Therapies**: The company plans to integrate various treatment modalities, including neuroplastic drugs, TMS, hyperbaric oxygen therapy, and digital therapeutics, to create a comprehensive treatment approach for suicidal depression and PTSD [22][24] - **Cost-Effectiveness**: The treatment courses proposed by NRx Pharmaceuticals are expected to be significantly less expensive than traditional interventions for other serious health conditions, costing less than $10,000 [23] Government and Regulatory Support - **Administration Focus**: The current administration has prioritized mental health, particularly veteran suicide prevention, indicating a supportive environment for innovative treatments like those being developed by NRx Pharmaceuticals [24][25] Conclusion - NRx Pharmaceuticals is positioned to address critical gaps in the treatment of suicidal ideation and depression through innovative drug development and integrated therapeutic approaches, with significant market potential and supportive regulatory pathways ahead [3][4][22]